Risks and benefits key to psychotropic use during pregnancy and postpartum period

JAMA. 2005 Oct 5;294(13):1604-8. doi: 10.1001/jama.294.13.1604.
No abstract available

Publication types

  • News

MeSH terms

  • Anxiety Disorders / drug therapy*
  • Bipolar Disorder / drug therapy
  • Depression, Postpartum / drug therapy*
  • Female
  • Humans
  • Mood Disorders / drug therapy*
  • Postpartum Period
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Psychotropic Drugs / therapeutic use*
  • Risk Assessment

Substances

  • Psychotropic Drugs